Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion

NCT05992220 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

138

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Hepatocellular Cancer
Hepatocellular Carcinoma Non-resectable
Hepatocellular Carcinoma Stage IV
Liver Cancer

Interventions

RADIATION: Atezolizumab plus bevacizumab, combined EBRT to vascular invasion
DRUG: Atezolizumab plus bevacizumab

Sponsor

Asan Medical Center

Collaborators

[object Object]
[object Object]
[object Object]